Home » Stocks » ZFGN

Zafgen, Inc. (ZFGN)

May 29, 2020 - ZFGN merged into LRMR
Stock Price: $0.990 USD 0.000 (0.00%)
Updated May 28, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap 37.10M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 37.47M
EPS (ttm) -0.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day May 28, 2020
Last Price $0.990
Previous Close $0.990
Change ($) 0.000
Change (%) 0.00%
Day's Open 1.020
Day's Range 10.000 - 12.510
Day's Volume 4,323,149
52-Week Range 0.619 - 12.510

More Stats

Market Cap 37.10M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 37.47M
Float 28.46M
EPS (basic) -0.97
EPS (diluted) -0.96
FCF / Share -0.92
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 523,135
Short Ratio 2.48
Short % of Float 1.84%
Beta 0.27
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 0.73
Revenue n/a
Operating Income -35.94M
Net Income n/a
Free Cash Flow -34.27M
Net Cash 44.45M
Net Cash / Share 1.19
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -20.65%
ROE -53.93%
ROIC -56.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$9.36*
Low
9.36
Current: $0.990
High
9.36
Target: 9.36
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue--------
Operating Income-45.65-61.12-53.00-58.23-73.81-35.53-13.78-13.79
Net Income-45.41-61.37-52.03-57.88-74.29-36.48-14.03-13.88
Shares Outstanding37.3532.2327.4327.3026.7612.190.730.71
Earnings Per Share-1.22-1.90-1.90-2.12-2.78-3.00-19.53-19.65
Operating Cash Flow-40.78-51.49-43.78-51.98-59.55-28.24-15.00-13.59
Capital Expenditures-1.35-0.11-0.06-0.66-0.60-0.06-0.02-
Free Cash Flow-42.13-51.60-43.84-52.64-60.15-28.30-15.02-13.59
Cash & Equivalents71.6011810212918511535.52-
Total Debt22.5820.6420.003.596.397.56--
Net Cash / Debt49.0297.4382.0512617910835.52-
Assets80.7312210613218911838.14-
Liabilities27.1128.4927.299.8920.0013.082.92-
Book Value53.6293.2778.22122169104-68.57-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zafgen, Inc.
Country United States
Employees 7
CEO Jeffrey S. Hatfield

Stock Information

Ticker Symbol ZFGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ZFGN
IPO Date June 19, 2014

Description

Zafgen is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA.